盐酸米多君是一种前体药,并经酶促水解,代谢为药理学上有活性物质脱甘氨酸米多君。脱甘氨酸米多君选择性地刺激外周a-肾上腺素能受体。此药对心肌β-肾上腺素能受体无作用。其他作用基本相当于其他似a-交感神经药的作用。
目的评价盐酸米多君(管通)治疗女性压力性尿失禁的有效性和安全性。
Objective to evaluate the efficacy and tolerability of midodrine (Gutron) in female patients with stress incontinence.
因这些药物生产企业未递交盐酸米多君上市后再研究所需要确认患者获益的临床证据,因此,FDA提议撤消盐酸米多君的上市许可。
Since the companies have not been able to provide evidence to confirm the drug's benefit, the FDA is pursuing a withdrawal of the product.
应用推荐